These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 193324)

  • 1. [Use of the passive hemagglutination test for the purpose of determining antibody levels following animal immunization with Cl. perfringens toxoid].
    Shemanova GF; Dmitrieva LN; Vlasova EV; Panteleev EI; Moshiashvili IIa
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):85-8. PubMed ID: 193324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I: preliminary observations in man in Papua New Guinea.
    Walker PD; Foster WH; Knight PA; Freestone DS; Lawrence G
    J Biol Stand; 1979; 7(4):315-23. PubMed ID: 231605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of allicin as feed additive to enhance vaccination capacity of Clostridium perfringens toxoid in rabbits.
    Abu El Hammed W; Soufy H; El-Shemy A; Nasr SM; Dessouky MI
    Vaccine; 2016 Apr; 34(17):2000-7. PubMed ID: 26973070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
    Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Homogeneous Cl. perfringens alpha-anatoxin: its physicochemical and immunogenic properties].
    Shemanova GF; Petrov RV; Dmitrieva LN; Panteleev EI; Drachev VA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):117-22. PubMed ID: 208330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitoxin titer in colostrum and milk after vaccination of sows with Clostridium perfringens type C toxoid vaccine.
    Djurickovic SM; Dworak JE; Wickham KL
    Vet Med Small Anim Clin; 1975 Mar; 70(3):283-5. PubMed ID: 164076
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
    Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
    Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of highly purified -toxoid of Clostridium perfringens.
    Sato H; Kameyama S; Murata R
    Jpn J Med Sci Biol; 1972 Feb; 25(1):53-6. PubMed ID: 4338981
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immune response of mice of different inbred lines to Clostridium oedematiens anatoxin].
    Petrov RV; Panteleev EI; Moshiashvili IIa; Shemanova GF; Vlasova EV
    Biull Eksp Biol Med; 1977 Feb; 83(2):198-200. PubMed ID: 558013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
    Shemanova GF; Vlasova EV; Sergeeva TI; Panteleyev EI
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid.
    Ito A
    Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunization against gas gangrene and tetanus with sexta-anatoxin (in experiments with animals)].
    Vlasova EV; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):113-6. PubMed ID: 4315881
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
    Sergeeva TI; Dolgikh MS; Blagoveshchenskiĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECIFIC PRECOCIOUS PROTECTIVE ACTION OF TOXOIDS.
    MELLANBY J; VANHEYNINGEN WE
    Nature; 1964 Jul; 203():312-3. PubMed ID: 14201781
    [No Abstract]   [Full Text] [Related]  

  • 16. The standardization of Cl. perfringens antigens and antisera.
    Jansen BC
    Dev Biol Stand; 1976; 32():35-44. PubMed ID: 187510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
    Jiang Z; De Y; Chang J; Wang F; Yu L
    Microbiol Immunol; 2014 Nov; 58(11):621-7. PubMed ID: 25197030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of clostridium sordellii LT and HT toxoids against challenge with spores in guinea pigs.
    Amimoto K; Oishi E; Yasuhar H; Sasak O; Katayama S; Kitajima T; Izumida A; Hirahara T
    J Vet Med Sci; 2001 Aug; 63(8):879-83. PubMed ID: 11558543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
    Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.